Unlocking CAR T cell potential: Inosine-induced stemness and enhanced potency

Xingying Zhang1, Haoyi Wang2

  • 1State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, 100101 Beijing, China.

Cancer Cell
|January 26, 2024
PubMed

Insights

Adenosine promotes tumor immune suppression. Researchers found that increasing adenosine deaminase (ADA-OE) or using inosine (INO) boosts CAR T-cell function and stemness, offering new therapeutic strategies.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Adenosine (Ado) is a key mediator of immune suppression within the tumor microenvironment.
  • Understanding adenosine's role is crucial for developing effective cancer immunotherapies.

Purpose of the Study:

  • To investigate the mechanisms of adenosine-mediated immunosuppression in tumors.
  • To evaluate the impact of modulating adenosine metabolism on CAR T-cell functionality and stemness.

Main Methods:

  • Overexpression of adenosine deaminase (ADA-OE) in tumor models.
  • Exposure of CAR T-cells to inosine (INO).
  • Assessment of CAR T-cell function, stemness features, and tumor immune suppression.

Main Results:

  • Overexpression of adenosine deaminase (ADA-OE) led to the metabolism of adenosine to inosine (INO).
  • Both ADA-OE and direct inosine exposure enhanced CAR T-cell functionality.
  • Inosine exposure induced stemness features in CAR T-cells, improving their anti-tumor potential.

Conclusions:

  • Modulating adenosine metabolism, specifically by increasing inosine levels, can overcome adenosine-driven immunosuppression.
  • Enhancing CAR T-cell stemness and function through inosine presents a promising strategy for improving cancer immunotherapy outcomes.

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K